Terms: = Breast cancer AND TRB
14 results:
1. Analysis of tumor infiltrating CD4+ and CD8+ CDR3 sequences reveals shared features putatively associated to the anti-tumor immune response.
Aran A; Lázaro G; Marco V; Molina E; Abancó F; Peg V; Gión M; Garrigós L; Pérez-García J; Cortés J; Martí M
Front Immunol; 2023; 14():1227766. PubMed ID: 37600765
[TBL] [Abstract] [Full Text] [Related]
2. Anti-VEGF and Anti-EGFR Antibody Therapy on T-Cell Infiltration and TCR Variation in Metastatic Colorectal cancer.
Xu M; Tsunedomi R; Kiyotani K; Tomochika S; Furuya K; Nakajima M; Matsui H; Tokumitsu Y; Shindo Y; Yoshida S; Iida M; Suzuki N; Takeda S; Ioka T; Hazama S; Nagano H
Anticancer Res; 2023 Feb; 43(2):613-620. PubMed ID: 36697107
[TBL] [Abstract] [Full Text] [Related]
3. Transretinal biopsy via 23-gauge pars plana vitrectomy for retinal and choroidal tumors: cytopathological results, surgical complications, and patient outcomes.
Gündüz AK; Mirzayev I; Ceyhan K; Özalp Ateş FS
Jpn J Ophthalmol; 2021 Mar; 65(2):250-260. PubMed ID: 33420856
[TBL] [Abstract] [Full Text] [Related]
4. Preclinical development of T-cell receptor-engineered T-cell therapy targeting the 5T4 tumor antigen on renal cell carcinoma.
Xu Y; Morales AJ; Cargill MJ; Towlerton AMH; Coffey DG; Warren EH; Tykodi SS
Cancer Immunol Immunother; 2019 Dec; 68(12):1979-1993. PubMed ID: 31686124
[TBL] [Abstract] [Full Text] [Related]
5. Conjugated Physiological Resveratrol Metabolites Induce Senescence in breast cancer Cells: Role of p53/p21 and p16/Rb Pathways, and ABC Transporters.
Giménez-Bastida JA; Ávila-Gálvez MÁ; Espín JC; González-Sarrías A
Mol Nutr Food Res; 2019 Nov; 63(22):e1900629. PubMed ID: 31441212
[TBL] [Abstract] [Full Text] [Related]
6. Immune receptor recombinations from breast cancer exome files, independently and in combination with specific HLA alleles, correlate with better survival rates.
Tong WL; Callahan BM; Tu YN; Zaman S; Chobrutskiy BI; Blanck G
Breast Cancer Res Treat; 2019 Jan; 173(1):167-177. PubMed ID: 30229447
[TBL] [Abstract] [Full Text] [Related]
7. Analysis of T cell receptor repertoire based on Vβ chain in patients with breast cancer.
Faghih Z; Deihimi S; Talei A; Ghaderi A; Erfani N
Cancer Biomark; 2018; 22(4):733-745. PubMed ID: 29945345
[TBL] [Abstract] [Full Text] [Related]
8. CCR8 Expression Defines Tissue-Resident Memory T Cells in Human Skin.
McCully ML; Ladell K; Andrews R; Jones RE; Miners KL; Roger L; Baird DM; Cameron MJ; Jessop ZM; Whitaker IS; Davies EL; Price DA; Moser B
J Immunol; 2018 Mar; 200(5):1639-1650. PubMed ID: 29427415
[TBL] [Abstract] [Full Text] [Related]
9. Out-of-pocket costs for cancer survivors between 5 and 10 years from diagnosis: an Italian population-based study.
Baili P; Di Salvo F; de Lorenzo F; Maietta F; Pinto C; Rizzotto V; Vicentini M; Rossi PG; Tumino R; Rollo PC; Tagliabue G; Contiero P; Candela P; Scuderi T; Iannelli E; Cascinu S; Aurora F; Agresti R; Turco A; Sant M; Meneghini E; Micheli A
Support Care Cancer; 2016 May; 24(5):2225-2233. PubMed ID: 26573280
[TBL] [Abstract] [Full Text] [Related]
10. microRNAs 424 and 503 are mediators of the anti-proliferative and anti-invasive action of the thyroid hormone receptor beta.
Ruiz-Llorente L; Ardila-González S; Fanjul LF; Martínez-Iglesias O; Aranda A
Oncotarget; 2014 May; 5(10):2918-33. PubMed ID: 24796297
[TBL] [Abstract] [Full Text] [Related]
11. Targeted abrogation of diverse signal transduction cascades by emodin for the treatment of inflammatory disorders and cancer.
Shrimali D; Shanmugam MK; Kumar AP; Zhang J; Tan BK; Ahn KS; Sethi G
Cancer Lett; 2013 Dec; 341(2):139-49. PubMed ID: 23962559
[TBL] [Abstract] [Full Text] [Related]
12. Anti-proliferative effect of atrial natriuretic peptide on colorectal cancer cells: evidence for an Akt-mediated cross-talk between NHE-1 activity and Wnt/β-catenin signaling.
Serafino A; Moroni N; Psaila R; Zonfrillo M; Andreola F; Wannenes F; Mercuri L; Rasi G; Pierimarchi P
Biochim Biophys Acta; 2012 Jun; 1822(6):1004-18. PubMed ID: 22387884
[TBL] [Abstract] [Full Text] [Related]
13. CD44-targeting for antitumor drug delivery: a new SN-38-hyaluronan bioconjugate for locoregional treatment of peritoneal carcinomatosis.
Serafino A; Zonfrillo M; Andreola F; Psaila R; Mercuri L; Moroni N; Renier D; Campisi M; Secchieri C; Pierimarchi P
Curr Cancer Drug Targets; 2011 Jun; 11(5):572-85. PubMed ID: 21486216
[TBL] [Abstract] [Full Text] [Related]
14. Expression of human tumor mucin-associated carbohydrate epitopes, including sialylated Tn, and localization of murine monoclonal antibodies CC49 and B72.3 in a syngeneic rat colon carcinoma model.
O'Boyle KP; Goya V; Zuckier LS; Chun S; Bhargava K
J Immunother Emphasis Tumor Immunol; 1994 Nov; 16(4):251-61. PubMed ID: 7533599
[TBL] [Abstract] [Full Text] [Related]
